Question 1

Who are the top researchers at Teva Pharmaceuticals (Netherlands)?

Accepted Answer

Ranked on the quality score, GUILHERME G SAFIOTI, Maurice T. Driessen and Tanisha D. Hill lead among researchers whose main affiliation is Teva Pharmaceuticals (Netherlands).

Question 2

What are the most cited papers from Teva Pharmaceuticals (Netherlands)?

Accepted Answer

The most cited paper from Teva Pharmaceuticals (Netherlands) is "Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial" (Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning et al., 2019), with 445 citations. Next come "Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling" (354) and "Digital technologies and adherence in respiratory diseases: the road ahead" (144).

Question 3

Which research topics does Teva Pharmaceuticals (Netherlands) publish most on?

Accepted Answer

By volume in 2022-now: Migraine and Headache Studies, Inhalation and Respiratory Drug Delivery, Ultrasound and Hyperthermia Applications and Asthma and respiratory diseases.

Question 4

Which keywords describe research at Teva Pharmaceuticals (Netherlands)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Neurological Disorders, Migraine, Calcitonin Gene-Related Peptide, Headache Disorders, Inhaler Devices, Pulmonary Drug Delivery, Nanoparticles and Genetics.

Question 5

Which fields of science does Teva Pharmaceuticals (Netherlands) work in?

Accepted Answer

In 2022-now, 63% of research at Teva Pharmaceuticals (Netherlands) is in Health Sciences, 13% in Social Sciences. Its largest fields are Medicine (62%), Engineering (10%), Social Sciences (9%). It does 2.1× the world's share of Health Sciences.

Question 6

Is Teva Pharmaceuticals (Netherlands)'s research output growing?

Accepted Answer

Output in 2022-2025 was 42% higher than in 2018-2021.